SCHEMBL2970232

SCHEMBL2970232

Cc1cc2cccc(Br)c2cc1C1C=Cc2ccccc21

nearest known ligand 0.31

Predicted protein targets (top 7)

geneUniProtsupporting neighboursconfidence
MAOA P21397 1/20 0.31
MAOB P27338 1/20 0.31
TDP1 Q9NUW8 1/20 0.30
ALDH1A1 P00352 1/20 0.30
MEN1 O00255 1/20 0.30
GAA P10253 1/20 0.30
KMT2A Q03164 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2959814 0.95 MAOA (0.31) MAOAMAOBALDH1A1MEN1GAA
SCHEMBL2960983 0.85 TDP1 (0.31) TDP1ALDH1A1
SCHEMBL2971830 0.84 CYP1A2 (0.42) MAOAMAOBALDH1A1
SCHEMBL27640461 0.82 SIGMAR1 (0.33) TDP1
SCHEMBL2959780 0.82 CYP1A2 (0.33) ALDH1A1
SCHEMBL2972562 0.81 CYP1A2 (0.39) MAOAMAOBALDH1A1
SCHEMBL2962076 0.80 SIGMAR1 (0.31) ALDH1A1
SCHEMBL2964360 0.80 SIGMAR1 (0.31) ALDH1A1
SCHEMBL2967629 0.78 KDM4E (0.33) MEN1GAAKMT2A
SCHEMBL2958356 0.78 SLC9A1 (0.33) MEN1GAAKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7763562-B2 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. (US) 2010-07-27 US disclosed
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization EXXONMOBIL CHEMICAL PATENTS INC. 2007-06-14 US disclosed
WO-2006065809-A2 HETEROATOM BRIDGED METALLOCENE COMPOUNDS FOR OLEFIN POLYMERIZATION EXXONMOBIL CHEMICAL PATENTS INC. (US) 2006-06-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070135597-A1 Heteroatom bridged metallocene compounds for olefin polymerization AP2M1, AP1M1, PYM1 MAOA 958/4885MAOB 902/4885TDP1 4183/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.